Plain-English translation of NCT06335888 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Giant Cell Arteritis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Giant cell arteritis is a condition where blood vessels become inflamed, usually in older adults. This study is testing a new imaging scan called 18F- to see if it can better detect this inflammation than the standard imaging scan doctors currently use. The medication targets immune cells in inflamed blood vessels, which may help doctors distinguish between inflammation and other problems like hardened arteries.
The standard imaging scan used today cannot reliably tell the difference between inflammation of blood vessels and atherosclerosis (hardening of arteries). Researchers believe this new treatment may be more specific at finding inflammation, which could help doctors diagnose and treat patients more accurately.
You likely qualify if…
You likely don't qualify if…
You will receive two imaging scans during the study—one using the new 18F- scan and one using the standard scan. The order may vary: some participants will receive the new scan first, others the standard scan first. Each scan takes about 45 minutes, and you'll need to fast for 6 hours before the scan with the standard imaging agent. The study is conducted at a single hospital location, and you'll work with the research team to schedule both scans.
AI-generated summary from trial data · Oct 5, 2026 · Not medical advice
Switzerland